An international team of immunologist studying the effects
of cannabis has discovered how smoking marijuana can trigger a suppression of
the body's immune functions.
The research, published in the European Journal of
Immunology, reveals why cannabis users are more susceptible to certain types of
cancers and infections.
The team led by Dr. Prakash Nagarkatti from the University
of South Carolina, focused their research on cannabinoids, a group of compound
found inside the cannabis plant, including THC (delta-9 tetahydrocannabinol),
which is already used for medical purposes such as pain relief.
“Cannabis is one of the most widely used drugs of abuse
worldwide and it is already believed to suppress immune functions making the
user more susceptible to infections and some types of cancer,” said Nagarkatti.
“It was believed that the key to this suppression is a unique type of immune
cell, which has only recently been identified by immunologists, called
myeloid-derived suppressor cells, MDSCs.”
While most immune cells fight against infections and cancers
to protect the host, MDSCs actively suppresses the immune system. The presence
of these cells is known to increase in cancer patients and it is believed that
MDSCs may suppress the immune system against cancer therapy, actually promoting
cancer growth.
Nagarkatti’s team demonstrated that cannabinoids could
trigger a massive number of MDSCs through activation of cannabinoid receptors. This
research reveals, for the first time, that marijuana cannabinoids might
suppress the immune system by activating these unique cells.
“These results raised interesting questions on whether increased
susceptibility to certain types of cancers or infections caused from smoking
marijuana results from induction of MDSCs seem to be unique and important cells
that may be triggered by inappropriate production of certain growth factors by
cancer cells or other chemical agents such as cannabinoids, which led to a
suppression of the immune system’s response.”
In a related study, also published in the European Journal
of immunology, Dr Christian, Vosshenrich from the institute Pasteur in Paris
reveals that when cancer cells grows, they produce a molecule called
interleukin-1 (IL-1), which also triggers MDSCs. This study identifies MDSCs
produced during cancer growth also weaken the ability of immune cells to kill
cancer cells.
Marijuana cannabinoids present us with a double edged sword,”
concluded Nagarkatti. “On one hand due to, due to their Immuno suppressive
nature, they can cause increased susceptibility to cancer and infections. However,
further research can provide opportunities to treat a large number of clinical
disorders where suppressing the immune response is actually beneficial.”
0 comments:
Post a Comment